| |||||||
|
Mobile Enterprise Solutions: Assessing the Market Opportunities for the Pharmaceutical Industry Introduction The pharmaceutical industry, particularly in the US, has been an early adopter of mobile field sales solutions. Pharmaceutical companies have a significant portion of executives and employees that are mobile workers, prompting this earlier adoption. Pharma companies will need to align their investment in mobile enterprise solutions with the evolution of the enterprise mobile device market. Scope Assesses the current competitive landscape of the leading mobile device manufacturers Evaluates the different companies offering operating system software, which supports and manages applications run on mobile devices Presents case studies on how leading mobile solution providers have worked with pharmaceutical companies Examines the future of the enterprise mobile device market and its impact on the pharmaceutical industry Report Highlights The requirements of the employees using the mobile enterprise solution should be a principal consideration when selecting a mobile device. These requirements will largely depend on the role and responsibilities of the particular mobile employee. The functionality and portability of a device should serve as key selection criteria. In selecting mobile devices as part of a mobile enterprise solution, pharmaceutical companies should consider the strengths of each manufacturer’s existing and future offerings. Reasons to Purchase Learn how enterprise mobile solutions can provide you with greater efficiency in knowledge management and reduced costs through economies of scale Understand the current and prospective enterprise mobile device market so as to optimize your return on investment from mobile enterprise solutions Know which companies are the leading mobile device manufacturers and how the competitive dynamics will prospectively evolve. January 2004 Pages: 57 Publisher: Datamonitor eHealthcare Pharma 2004 To order go to this URL: http://www.bioportfolio.com/cgi-bin/acatalog/Datamonitor_eHealthcare_Pharma_2004.html#a545 |
|